Reunion Neuroscience is committed to innovating therapeutic solutions to treat mental health conditions through the development of novel psychedelic compounds. NASDAQ:REUN 


Life Sciences

Therapeutics

Reunion Neuroscience

Greg Mayes

Nathan Bryson

Curtis Weber

Robert Alexander

Mark Theeuwes

Edward Smith

The Leadership Team at Reunion Neuroscience steers the strategic direction and operational execution of the company. Comprising top executives such as the Chief Scientific Officer, Chief Operating Officer, President & CEO, Chief Financial Officer, and Chief Medical Officer, this team oversees the development of novel psychedelic compounds for mental health treatments, ensures financial stability, maintains rigorous quality standards, and drives overall corporate governance.

Leadership Team

The Finance and Administration Team at Reunion Neuroscience oversees the financial health and operational efficiency of the company. They manage budgeting, financial reporting, and strategic financial planning, while also ensuring compliance and quality management within administrative functions. This team plays a crucial role in supporting the company's mission to innovate therapeutic solutions for mental health through novel psychedelic compounds.

Finance and Administration Team

The Medical and Clinical Team at Reunion Neuroscience, comprising the Chief Medical Officer, Medical Director, and Clinical Trial Associate, is dedicated to overseeing the development and execution of clinical trials for novel psychedelic compounds. Their primary focus is to ensure safety, efficacy, and regulatory compliance in the innovative treatment of mental health conditions.

Reunion Neuroscience

Org chart

Teams

Leadership Team

Finance and Administration Team

Medical and Clinical Team

Offices

Reunion Neuroscience

Org chart

Teams

Leadership Team

Finance and Administration Team

Medical and Clinical Team

Offices

Related companies